Cengild Medical Bhd (XKLS:0243) Beta: -0.4691 (As of Jul. 03, 2026)


XKLS:0243 Cengild Medical Bhd XKLS:0243
67 GF Score
Price RM0.20
GF Value RM0.29
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cengild Medical Bhd Beta?

Cengild Medical Bhd XKLS:0243 67 Beta is -0.4691 as of Jul. 03, 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 67/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-03), Cengild Medical Bhd's Beta is -0.4691.


Cengild Medical Bhd  (XKLS:0243) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cengild Medical Bhd Beta Related Terms


Cengild Medical Bhd Beta Historical Data

* Premium members only.

The historical data trend for Cengild Medical Bhd's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cengild Medical Bhd Beta Chart

Cengild Medical Bhd Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.17

Cengild Medical Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.17 -0.41 -0.39 -0.36

XKLS:0243 vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Cengild Medical Bhd's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cengild Medical Bhd Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's Beta distribution charts can be found below:

* The bar in red indicates where Cengild Medical Bhd's Beta falls into.


XKLS:0243
67GF Score
Cengild Medical Bhd XKLS:0243
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cengild Medical Bhd Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.4691 mean?
Cengild Medical Bhd (XKLS:0243) has a Beta of -0.4691 as of Jul. 03, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cengild Medical Bhd and its competitors.
Is Cengild Medical Bhd's Beta too high?
Cengild Medical Bhd's current Beta is -0.4691. Overall, Cengild Medical Bhd has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Beta compare to HCA and THC?
Cengild Medical Bhd's Beta of -0.4691 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current Beta is -0.4691. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.20 — trading 31% below its estimated fair value. The current Beta is -0.4691. Cengild Medical Bhd's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Beta is -0.4691 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?

Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued. The current stock price of RM0.20 is trading 31% below its estimated GF Value™ of RM0.29. GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.

Key valuation signals for XKLS:0243:

  • Beta: -0.4691
  • GF Value™: RM0.29 vs. price of RM0.20 (31% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cengild Medical Bhd Business Description

Address No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
67GF Score

Get the complete analysis for XKLS:0243

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.20
Price
RM0.29
GF Value